• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

髓外造血中的门静脉高压和腹水

Portal hypertension and ascites in extramedullary hematopoiesis.

作者信息

Amarapurkar Pooja, Parekh Sunil, Amarapurkar Anjali, Amarapurkar Deepak

机构信息

Department of Gastroenterology & Hepatology, Bombay Hospital and Medical Research Center, Hematology Laboratory, Mumbai, Maharashtra.

Dr Sunil Parekh's Lab & Consultant Histopathology, Mumbai, Maharashtra.

出版信息

J Clin Exp Hepatol. 2012 Jun;2(2):188-90. doi: 10.1016/S0973-6883(12)60107-8. Epub 2012 Jul 21.

DOI:10.1016/S0973-6883(12)60107-8
PMID:25755427
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3940412/
Abstract

Myeloproliferative diseases (MPD) are clonal stem cell disorders which mainly include polycythemia vera (PV), essential thrombocythemia (ET), and idiopathic myelofibrosis (IMF). They are characterized by leucocytosis, thrombocytosis, erythrocytosis, splenomegaly, and bone marrow hypercellularity. This might also result in extramedullary hematopoiesis. Abdominal manifestation has been recognized as a feature of these disorders. Splenomegaly and hepatomegaly are fairly common as opposed to ascites which is rare. The MPDs mainly affect the hepatic circulatory systems. The common hepatic manifestations are Budd-Chiari syndrome (BCS), portal vein thrombosis (PVT), and nodular regenerative hyperplasia. A few other features seen in MPDs are caused by extramedullary hematopoiesis, increased hepatic blood flow, and secondary hemosiderosis from multiple blood transfusions. Portal hypertension is found in up to 7% of patients. We report a case of portal hypertension with ascites in a patient with extramedullary hematopoiesis treated with transjugular intrahepatic portocaval shunt (TIPS).

摘要

骨髓增殖性疾病(MPD)是克隆性干细胞疾病,主要包括真性红细胞增多症(PV)、原发性血小板增多症(ET)和原发性骨髓纤维化(IMF)。它们的特征是白细胞增多、血小板增多、红细胞增多、脾肿大和骨髓细胞增多。这也可能导致髓外造血。腹部表现已被认为是这些疾病的一个特征。脾肿大和肝肿大相当常见,而腹水则很少见。MPD主要影响肝循环系统。常见的肝脏表现为布加综合征(BCS)、门静脉血栓形成(PVT)和结节性再生性增生。MPD中出现的其他一些特征是由髓外造血、肝血流量增加和多次输血导致的继发性含铁血黄素沉着症引起的。高达7%的患者存在门静脉高压。我们报告一例接受经颈静脉肝内门体分流术(TIPS)治疗的髓外造血患者出现门静脉高压伴腹水的病例。

相似文献

1
Portal hypertension and ascites in extramedullary hematopoiesis.髓外造血中的门静脉高压和腹水
J Clin Exp Hepatol. 2012 Jun;2(2):188-90. doi: 10.1016/S0973-6883(12)60107-8. Epub 2012 Jul 21.
2
Budd-Chiari syndrome following laparoscopic cholecystectomy.腹腔镜胆囊切除术后布加综合征
J Clin Exp Hepatol. 2013 Sep;3(3):256-9. doi: 10.1016/j.jceh.2013.07.001. Epub 2013 Jul 31.
3
Spontaneous erythroid colony formation as the clue to an underlying myeloproliferative disorder in patients with Budd-Chiari syndrome or portal vein thrombosis.自发性红系集落形成作为布加综合征或门静脉血栓形成患者潜在骨髓增殖性疾病的线索。
Semin Thromb Hemost. 1997;23(5):411-8. doi: 10.1055/s-2007-996117.
4
Noncirrhotic portal hypertension.非肝硬化性门静脉高压症
J Clin Exp Hepatol. 2011 Sep;1(2):94-108. doi: 10.1016/S0973-6883(11)60128-X. Epub 2011 Nov 9.
5
A Case of Budd-Chiari Syndrome Associated With Antiphospholipid Syndrome Treated Successfully by Transjugular Intrahepatic Portosystemic Shunt.1例布加综合征合并抗磷脂综合征经颈静脉肝内门体分流术成功治疗的病例
Clin Med Insights Case Rep. 2022 May 18;15:11795476221100595. doi: 10.1177/11795476221100595. eCollection 2022.
6
Budd-Chiari syndrome treated with direct intrahepatic portocaval shunt: A case report.经直接肝内门体分流术治疗的布加综合征:一例报告。
Radiol Case Rep. 2024 Apr 13;19(7):2608-2612. doi: 10.1016/j.radcr.2024.03.036. eCollection 2024 Jul.
7
Budd-Chiari syndrome and acute portal vein thrombosis: management by a transjugular intrahepatic portosystemic shunt (TIPS) and portal vein interventions via a TIPS.布加综合征与急性门静脉血栓形成:经颈静脉肝内门体分流术(TIPS)及通过TIPS进行门静脉干预的治疗
J Gastrointest Surg. 2006 Mar;10(3):417-21. doi: 10.1016/j.gassur.2005.07.019.
8
Diagnosis, pathogenesis and treatment of the myeloproliferative disorders essential thrombocythemia, polycythemia vera and essential megakaryocytic granulocytic metaplasia and myelofibrosis.骨髓增殖性疾病(原发性血小板增多症、真性红细胞增多症、原发性巨核细胞粒细胞化生及骨髓纤维化)的诊断、发病机制与治疗
Neth J Med. 1999 Feb;54(2):46-62. doi: 10.1016/s0300-2977(98)00143-0.
9
Clinical and pathological criteria for the diagnosis of essential thrombocythemia, polycythemia vera, and idiopathic myelofibrosis (agnogenic myeloid metaplasia).原发性血小板增多症、真性红细胞增多症和原发性骨髓纤维化(特发性髓样化生)诊断的临床及病理标准。
Int J Hematol. 2002 Aug;76(2):133-45. doi: 10.1007/BF02982575.
10
Good Clinical Outcomes in Budd-Chiari Syndrome with Hepatic Vein Occlusion.布加综合征合并肝静脉闭塞时的良好临床结局
Dig Dis Sci. 2016 Oct;61(10):3054-3060. doi: 10.1007/s10620-016-4208-0. Epub 2016 May 25.

引用本文的文献

1
Rare case of ascites several years after liver transplantation.肝移植数年之后出现腹水的罕见病例。
Gastroenterol Rep (Oxf). 2022 Dec 5;10:goac076. doi: 10.1093/gastro/goac076. eCollection 2022.
2
Osteopetrosis: a rare case of portal hypertension.骨硬化症:门静脉高压症的罕见病例。
Future Sci OA. 2022 Nov 15;8(8):FSO817. doi: 10.2144/fsoa-2022-0028. eCollection 2022 Sep.
3
Enigma portal: Peritoneal effusion in a patient with a myeloproliferative neoplasm.谜之门:骨髓增殖性肿瘤患者的腹腔积液。
Cytopathology. 2023 Jan;34(1):84-86. doi: 10.1111/cyt.13186. Epub 2022 Nov 4.
4
The Implications of Liver Biopsy Results in Patients with Myeloproliferative Neoplasms Being Treated with Ruxolitinib.芦可替尼治疗的骨髓增殖性肿瘤患者肝脏活检结果的意义
Case Rep Hematol. 2019 Jan 6;2019:3294046. doi: 10.1155/2019/3294046. eCollection 2019.
5
Splanchnic Vein Thrombosis in the Myeloproliferative Neoplasms.内脏静脉血栓形成在骨髓增殖性肿瘤中。
Curr Hematol Malig Rep. 2018 Jun;13(3):183-190. doi: 10.1007/s11899-018-0446-x.
6
Multicenter analysis of the use of transjugular intrahepatic portosystemic shunt for management of MPN-associated portal hypertension.经颈静脉肝内门体分流术用于治疗骨髓增殖性肿瘤相关门静脉高压症的多中心分析
Am J Hematol. 2017 Sep;92(9):909-914. doi: 10.1002/ajh.24798. Epub 2017 Jul 26.

本文引用的文献

1
Hematologic and oncologic diseases and the liver.血液学和肿瘤学疾病与肝脏。
Clin Liver Dis. 2011 Feb;15(1):69-87. doi: 10.1016/j.cld.2010.09.013.
2
Improving survival in patients with decompensated cirrhosis.提高失代偿期肝硬化患者的生存率。
J Gastroenterol Hepatol. 2010 Nov;25(11):1716-7. doi: 10.1111/j.1440-1746.2010.06515.x.
3
Ascites: diagnosis and management.腹水:诊断与管理
Med Clin North Am. 2009 Jul;93(4):801-17, vii. doi: 10.1016/j.mcna.2009.03.007.
4
Image of the month. Portal hypertension as a result of extramedullary hematopoiesis caused by idiopathic myelofibrosis.本月影像。特发性骨髓纤维化所致髓外造血引起的门静脉高压。
Clin Gastroenterol Hepatol. 2008 Apr;6(4):e22. doi: 10.1016/j.cgh.2008.01.008. Epub 2008 Mar 5.
5
A clinical and pathological study of seventy cases of myelofibrosis.70例骨髓纤维化的临床与病理研究
Ann Intern Med. 1962 Jul;57:73-84. doi: 10.7326/0003-4819-57-1-73.
6
Transjugular intrahepatic portosystemic shunt for treatment of portal hypertension due to extramedullary hematopoiesis in idiopathic myelofibrosis.经颈静脉肝内门体分流术治疗原发性骨髓纤维化髓外造血所致门静脉高压
Blood. 2002 Jun 1;99(11):4246-7. doi: 10.1182/blood-2002-01-0282.
7
The natural history of agnogenic myeloid metaplasia (AMM) and a critical evaluation of its relationship with the myeloproliferative syndrome.特发性骨髓化生(AMM)的自然病史及其与骨髓增殖综合征关系的批判性评估。
Medicine (Baltimore). 1971 Sep;50(5):357-420. doi: 10.1097/00005792-197109000-00001.
8
The serum-ascites albumin gradient is superior to the exudate-transudate concept in the differential diagnosis of ascites.血清腹水白蛋白梯度在腹水的鉴别诊断中优于渗出液-漏出液概念。
Ann Intern Med. 1992 Aug 1;117(3):215-20. doi: 10.7326/0003-4819-117-3-215.